Singapore startups leading the AI-healthcare revolution
Singapore startups are driving a new wave of innovation in healthcare. Artificial intelligence (AI) is at the core of this transformation. Backed by National AI Strategy 2.0 and support from agencies like SGInnovate, these startups are changing how healthcare is delivered.
They are solving real challenges—such as chronic diseases, workforce shortages, and aging populations. Their tools improve diagnostics, enable remote monitoring, and support faster clinical decisions. These advances reflect Singapore’s ambition to lead in smart health systems across Asia.
No longer experimental, these technologies are now deployed in hospitals and clinics. Singapore startups are delivering measurable improvements in healthcare quality and accessibility.
Emerging players reshaping healthcare innovation
Several companies are leading the way. One of the most prominent is Biofourmis. This digital therapeutics startup uses AI to monitor patients remotely and detect signs of health deterioration early. Biofourmis began in Singapore and now works with hospitals around the world.
Us2.ai is another strong example. It automates echocardiogram analysis using AI. The platform delivers results in under two minutes—a major improvement over the manual process, which takes up to 30 minutes. The company received FDA clearance in 2022 and now operates in Asia, Europe, and the US.
AEvice Health focuses on asthma care. It offers a wearable device that uses AI to detect early symptoms of asthma attacks. Their flagship product, AEviceMD, is undergoing trials in public hospitals. The company has received support from Enterprise Singapore.
These startups show that Singapore’s healthcare innovators can move fast, secure regulatory approvals, and scale globally. They represent a shift from research-stage innovation to real-world impact.
National support and broader economic impact
Singapore’s push for AI in healthcare is not accidental. Through Smart Nation, Startup SG, and AI Singapore, the government provides critical support. Startups benefit from research partnerships, regulatory guidance, and early-stage funding.
This alignment between public policy and private innovation is paying off. In 2023, Singapore led Southeast Asia in healthcare AI investment. The market is expected to exceed US$1.5 billion by 2025.
The benefits go beyond financial returns. AI reduces the load on hospitals, shortens wait times, and improves preventive care. It also supports underserved communities by making services more accessible and scalable.
Singapore business leaders are also shaping standards for responsible AI. They focus on explainability, safety, and patient privacy. These principles build trust in AI adoption and ensure long-term value.
Conclusion
Singapore startups are redefining healthcare with AI. From smarter diagnostics to better chronic care, their solutions are creating impact across the region.
With strong policy support and world-class research networks, Singapore is set to lead Asia’s health tech transformation. These startups are proof that bold innovation—done responsibly—can change lives.
Discover more inspiring journeys on Feature.Asia: 10 Entrepreneurs Under 30 Changing Asia’s Economy
